We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2379:TWSEDIP Corporation Analysis

Data as of 2026-05-18 - not real-time

NT$560.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Realtek Semiconductor Corp. trades at a price that sits above its discounted cash flow estimate, suggesting a degree of overvaluation despite a PE ratio that is substantially lower than the semiconductor industry average. The stock benefits from a robust dividend yield near five percent and a solid payout, though the payout ratio approaches ninety percent, raising questions about sustainability. Technical signals are mixed: the MACD histogram is negative and the signal line is bearish, while the RSI hovers around the neutral zone and the 20‑day SMA sits below the current price, indicating limited upside momentum in the short run.
On the fundamentals side, Realtek delivers strong profitability with ROE above 30%, healthy operating cash flow, and modest revenue growth. The beta is low, reflecting limited market volatility, yet the recent 30‑day volatility is relatively high, and the semiconductor sector carries inherent cyclical risk. Overall, the company presents a blend of value and growth characteristics, with dividend appeal offset by valuation concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating limited near‑term upside
  • Price comfortably above recent support level
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE ratio well below industry average suggesting value opportunity
  • Strong ROE and operating cash flow supporting earnings growth
  • Attractive dividend yield enhancing total return

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified semiconductor product portfolio with secular demand
  • Robust cash reserves and manageable debt level
  • Valuation gap relative to DCF fair value and high payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth4.00%
Profit Margin11.54%
P/E Ratio19.9
ROE31.62%
ROA6.37%
Debt/Equity24.95
P/B Ratio6.4
Op. Cash FlowNT$21.4B
Free Cash FlowNT$9.2B
Industry P/E38.2

Technical Analysis

TrendNeutral
RSI54.5
SupportNT$524.00
ResistanceNT$615.00
MA 20NT$551.90
MA 50NT$514.92
MA 200NT$520.58
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair ValueNT$381.51
Target PriceNT$587.00
Upside/Downside4.82%
GradeOvervalued
TypeBlend
Dividend Yield4.76%

Risk Assessment

Beta0.45
Volatility49.86%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.